BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3791370)

  • 1. [The effect of acromegaly treatment on glucose tolerance].
    Páv J; Marek J; Srámková J
    Cas Lek Cesk; 1986 Nov; 125(47):1451-4. PubMed ID: 3791370
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secretion of insulin in patients with disorders of glucose tolerance in relation to concurrent acromegaly].
    Páv J; Marek J; Srámková J
    Cas Lek Cesk; 1984 Dec; 123(49):1509-13. PubMed ID: 6394134
    [No Abstract]   [Full Text] [Related]  

  • 3. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [8 cases of acromegaly--with reference to glucose metabolism, thyroid and hypophyseal-adrenal cortical function].
    Mashimo K; Horiuchi Y; Takebe K; Hirama M; Nakagawa K
    Saishin Igaku; 1967 May; 22(5):1020-30. PubMed ID: 6078764
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of acromegaly, hypophysectomy and hypothyroidism on plasma glucose, insulin and free fatty acid responses to a glucose load.
    Gutman A; Shafrir E; Reches A; Chowers I
    Isr J Med Sci; 1972 Jun; 8(6):877-80. PubMed ID: 5051829
    [No Abstract]   [Full Text] [Related]  

  • 6. [The tolbutamide test in acromegaly. Preliminary observations].
    Massara F; Camanni F; Molinatti GM
    Minerva Med; 1966 Jan; 57(1):18-20. PubMed ID: 5903538
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metabolism tests in acromegaly].
    Albeaux-Fernet M
    Folia Clin Int (Barc); 1968 Jun; 18(6):339-41. PubMed ID: 4915852
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acromegaly by transethmoidal hypophysectomy.
    Richards SH; Thomas JP
    Q J Med; 1980; 49(193):21-31. PubMed ID: 6254108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cure of acromegaly by resection of pituitary tumor. Reestablishment of normal growth hormone secretion].
    Bachelot I; Muller JM; de Rougemont J; Tourniaire J
    Nouv Presse Med; 1973 Dec; 2(44):2945-8. PubMed ID: 4775176
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acromegaly. IV. Changes in glycide metabolism].
    Marek J; Páv J; Srámková J; Bleha O
    Cas Lek Cesk; 1973 Aug; 112(31):959-63. PubMed ID: 4727329
    [No Abstract]   [Full Text] [Related]  

  • 12. [Acromegaly].
    Zapf J
    Schweiz Rundsch Med Prax; 1984 Mar; 73(10):293-8. PubMed ID: 6709989
    [No Abstract]   [Full Text] [Related]  

  • 13. Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
    Wass JA
    J Endocrinol Invest; 2003; 26(7 Suppl):48-53. PubMed ID: 14604066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective clinical analysis of glucose metabolism in acromegaly patients.
    Zhou X; Gong Y; Tian J; Yang G; Li F; Li L; Ba J; Dou J; Mu Y
    Minerva Endocrinol; 2019 Jun; 44(2):233-235. PubMed ID: 30037183
    [No Abstract]   [Full Text] [Related]  

  • 15. Are there alternative tests for diagnosis of acromegaly?
    Popovic V
    J Endocrinol Invest; 2005; 28(11 Suppl International):73-4. PubMed ID: 16625850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in glucose tolerance after treatment for acromegaly.
    Fonseca V; Dandona P; Havard CW
    BMJ; 1989 Nov; 299(6708):1162. PubMed ID: 2513035
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of oral glucose tolerance in the diagnosis of acromegaly].
    von Werder K; Bottermann P; Hartmann P; Schwarz K
    Med Klin; 1972 Oct; 67(43):1398-401. PubMed ID: 4641922
    [No Abstract]   [Full Text] [Related]  

  • 18. GH but not IGF-I hypersecretion in acromegaly is generally attenuated in elderly acromegalics.
    Gaia D; Gasco V; Razzore P; Ciccarelli E; Camanni F; Ghigo E; Grottoli S
    J Endocrinol Invest; 2002; 25(10 Suppl):51-2. PubMed ID: 12508916
    [No Abstract]   [Full Text] [Related]  

  • 19. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U; Quabbe HJ
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GH and mortality in acromegaly.
    Sheppard MC
    J Endocrinol Invest; 2005; 28(11 Suppl International):75-7. PubMed ID: 16625851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.